U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) Director Peter Francis Minan bought 288 shares of the firm’s stock in a transaction dated Tuesday, June 9th. The shares were acquired at an average price of $61.50 per share, for a total transaction of $17,712.00. Following the acquisition, the director directly owned 3,211 shares of the company’s stock, valued at approximately $197,476.50. The trade was a 9.85% increase in their position. The purchase was disclosed in a filing with the SEC, which is available through the SEC website.
Peter Francis Minan also recently made the following trade(s):
- On Monday, June 8th, Peter Francis Minan purchased 492 shares of U.S. Physical Therapy stock. The stock was acquired at an average cost of $63.14 per share, with a total value of $31,064.88.
U.S. Physical Therapy Price Performance
NYSE USPH traded up $1.12 on Wednesday, hitting $62.92. 222,611 shares of the company were exchanged, compared to its average volume of 207,326. The firm has a 50 day moving average of $68.81 and a two-hundred day moving average of $76.42. The company has a market cap of $957.63 million, a P/E ratio of 125.84, a P/E/G ratio of 1.69 and a beta of 1.16. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.41. U.S. Physical Therapy, Inc. has a 1-year low of $58.19 and a 1-year high of $93.50.
U.S. Physical Therapy Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Friday, May 22nd will be given a $0.46 dividend. This represents a $1.84 annualized dividend and a yield of 2.9%. The ex-dividend date is Friday, May 22nd. U.S. Physical Therapy’s payout ratio is 368.00%.
Analyst Ratings Changes
Several research analysts recently weighed in on the stock. Barrington Research dropped their price objective on shares of U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating for the company in a research report on Wednesday, May 13th. Zacks Research upgraded shares of U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 27th. Jefferies Financial Group upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Thursday, March 12th. Citizens Jmp dropped their price objective on shares of U.S. Physical Therapy from $113.00 to $98.00 and set a “market outperform” rating for the company in a research report on Friday, May 8th. Finally, Citigroup restated an “outperform” rating on shares of U.S. Physical Therapy in a research report on Friday, May 8th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, U.S. Physical Therapy currently has a consensus rating of “Moderate Buy” and a consensus price target of $97.50.
Read Our Latest Report on USPH
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the stock. William Blair Investment Management LLC acquired a new stake in shares of U.S. Physical Therapy during the third quarter worth $29,381,000. American Century Companies Inc. acquired a new position in U.S. Physical Therapy in the third quarter valued at about $21,940,000. Bahl & Gaynor Inc. boosted its holdings in U.S. Physical Therapy by 47.6% during the third quarter. Bahl & Gaynor Inc. now owns 474,688 shares of the company’s stock worth $40,325,000 after buying an additional 153,054 shares during the last quarter. Bank of America Corp DE boosted its holdings in U.S. Physical Therapy by 77.2% during the third quarter. Bank of America Corp DE now owns 317,200 shares of the company’s stock worth $26,946,000 after buying an additional 138,194 shares during the last quarter. Finally, Schroder Investment Management Group grew its position in shares of U.S. Physical Therapy by 45.9% during the 4th quarter. Schroder Investment Management Group now owns 364,253 shares of the company’s stock worth $29,603,000 after buying an additional 114,618 shares during the period.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.
In addition to traditional rehabilitation services, U.S.
Featured Stories
- Five stocks we like better than U.S. Physical Therapy
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.
